Malignant diseases have been highlighted as one of the most prominent
causes of human mortality worldwide. The prevalence of cancer is constantly
increasing and is expected to reach three-fourths of the population in the next two
decades. Conventional cancer treatment involves surgery, controlling and reducing the
growth of cancer tissues using radiation, and chemotherapy. Many incidences prove
that chemical treatment for cancer is immensely associated with the recurrence of
cancer, and the development of resistance, and is prone to severe side effects. Since
natural products have now been used in the treatment of various diseases, the
anticancer properties of natural drugs and druggable products are interceded by various
mechanisms, including the initiation of programmed cell death, modulations in the
immune system, and inhibition of angiogenesis. Edible, medicinal plants and spices
used in traditional medicine to regulate vital molecular targets are important chemopreventive agents in the treatment of chemo and radiation therapy-induced toxicities in
drug development. Natural agents could trigger cell death signalling pathways in
tumour cells by stimulating anti-apoptotic proteins and/or overcoming pro-apoptotic
proteins and caspases. It inhibit protein kinase B (Akt), phosphatidylinositide 3-kinases
(PI3K), epidermal growth factor receptor/mitogen-activated protein kinase
(EGFR/MAPK), as well as nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-κB). Bax/Bcl-2 ratio changes, inhibiting cellular proliferation, and
differentiation, and also activating apoptosis lead to less prominence. To summarize,
this chapter highlights the current status, and forthcoming prospects of cancer treatment
and prevention as well as the potential of bioactive compounds that have been used in
cancer treatment and chemoprevention.
Keywords: Antioxidants, Bioactive compounds, Free radicals, Molecular targets and chemoprevention.
